Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Saline Bag and TEE During Cardiac Displacement
This completed trial evaluated the use of a saline bag and transesophageal echocardiography (TEE) during cardiac displacement.
-
CLINICAL_TRIALS research · 2012-08-01Clinical Trial Update: The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?
The WOMEN study has completed and investigates the optimal method for evaluating myocardial ischemia in women.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Magnetic Resonance Diabetic Cardiac Stress Imaging [Phase 4]
Phase 4 MRI-based diabetic cardiac stress imaging trial sponsored by Assistance Publique - Hôpitaux de Paris has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI [Phase 4]
Phase 4 trial comparing intensive statin regimens with atorvastatin versus rosuvastatin in elderly Chinese patients undergoing PCI; current …
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions [Phase 1]
The document reports the completion of a Phase 1 bioequivalence study evaluating clopidogrel 300 mg tablets under fasting conditions. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease [Phase 4]
Phase 4 trial evaluating whether amlodipine affects the action of antiplatelet therapy in patients with ischemic heart disease; status compl…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' clopidogrel bisulfate as an original application (ANDA), enabling a generic version of the antiplatel…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's Original Application for clopidogrel bisulfate, enabling a generic version of clopidogrel to be mark…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia [Phase 4]
A Phase 4 trial evaluating quinapril in women with chest pain and evidence of myocardial ischemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson [EARLY_Phase 1]
An early-phase 1 trial evaluating regadenoson as a pharmacologic stress agent for myocardial perfusion MRI in ischemic heart disease; the st…
-
CLINICAL_TRIALS research · 2012-03-13Clinical Trial Update: Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
Clinical trial update describing the evaluation of the PROMUS Element Everolimus-eluting coronary stent system for coronary revascularizatio…
-
CLINICAL_TRIALS research · 2012-03-02Clinical Trial Update: Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease [NA]
This clinical trial update compares the cost-effectiveness of Coronary CT Angiography versus Myocardial SPECT in patients at intermediate ri…
-
CLINICAL_TRIALS other · 2012-02-16Clinical Trial Update: The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting [Phase 4]
This Phase 4 clinical trial evaluates outcomes after coronary stenting in ischemic heart disease. The current status is unknown.
-
FDA label_change · 2012-02-08FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)
FDA approved a supplemental application for CardioGen-82 (rubidium chloride RB-82) to update its labeling.
-
CLINICAL_TRIALS research · 2012-01-12Clinical Trial Update: Community Pharmacy Assisting in Total Cardiovascular Health [NA]
An update on a University of Saskatchewan trial examining the role of community pharmacists in improving adherence to statin therapy to enha…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: ACTIONS - Aortic Counterpulsation to Improve Outcomes in Noncardiac Surgery [Phase 4]
Phase 4 ACTIONS trial evaluating aortic counterpulsation to improve outcomes in patients with ischemic heart disease and left ventricular dy…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests
In a completed trial, researchers evaluated whether the Duke Activity Status Index (DASI) could guide the selection of optimal cardiac stres…
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial [Phase 4]
The VELETI trial, a Phase 4 study evaluating paclitaxel-eluting strategies for moderate vein graft lesions in patients after coronary artery…
-
FDA approval · 2011-09-30FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for LEXISCAN (regadenoson) from Astellas Pharma US, expanding/updating its labeling.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: 123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients
A completed clinical trial assessing whether 123I-BMIPP SPECT imaging can help reduce cardiac events in patients undergoing hemodialysis.
-
FDA approval · 2011-08-17FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for Tenormin (atenolol) from Almatica Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Intravenous Versus Intracoronary Use of Abciximab [NA]
A completed clinical trial comparing intravenous versus intracoronary administration of abciximab in patients with atherosclerosis and ische…
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris [Phase 1, Phase 2]
A Phase 1/2 trial evaluated mobilized stem cell therapy using G-CSF and VEGF gene therapy in patients with stable severe angina due to ische…
-
FDA approval · 2011-07-06FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC. The action finalizes the r…
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery [Phase 4]
Phase 4 clinical trial update comparing etomidate and ketamine for anesthesia induction in patients undergoing coronary artery bypass graft …